In the Pacific region, limited pharmacy competition and distribution costs can affect medication pricing. Rybelsus® (Semaglutide, Oral tablet) by Novo Nordisk has been FDA-approved since 2019 for Type 2 diabetes. Weight Method offers a separate option for Milpitas residents: licensed California providers evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month — same pricing regardless of location.
FDA-approved Rybelsus prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · Milpitas is already seeing results
Rybelsus in Milpitas, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Rybelsus to patients in Milpitas from $199/month with virtual consultations and direct-to-door shipping.
Semaglutide targets the biological mechanisms involved in sustained weight regulation. By activating GLP-1 receptors in the brain, it can reduce hunger signals and slow gastric emptying. Novo Nordisk developed Rybelsus® as the FDA-approved Oral tablet product, taken Once daily, approved in 2019. Weight Method is a separate program: licensed providers in California evaluate eligible patients via telehealth and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program for eligible Milpitas, CA residents starts at $199/month.
Milpitas is home to a large and vibrant Hispanic community, and Weight Method is committed to providing culturally competent care. Our bilingual providers understand the dietary traditions, family dynamics, and health concerns common in Hispanic households — and they deliver consultations in English or Spanish. Weight Method prescribes compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. Semaglutide does not require abandoning cultural foodways; it works by reducing appetite so you naturally eat smaller portions of the foods you love.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Rybelsus from $199/month.
Get Started NowFree consultation. No commitment.